1. Home
  2. AUXX vs MLAB Comparison

AUXX vs MLAB Comparison

Compare AUXX & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gold X2 Mining Inc. Common Shares

AUXX

Gold X2 Mining Inc. Common Shares

N/A

Current Price

$4.08

Market Cap

427.7M

Sector

N/A

ML Signal

N/A

Logo Mesa Laboratories Inc.

MLAB

Mesa Laboratories Inc.

HOLD

Current Price

$128.01

Market Cap

719.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUXX
MLAB
Founded
N/A
1982
Country
Canada
United States
Employees
26
N/A
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
427.7M
719.9M
IPO Year
2026
1995

Fundamental Metrics

Financial Performance
Metric
AUXX
MLAB
Price
$4.08
$128.01
Analyst Decision
Strong Buy
Buy
Analyst Count
3
3
Target Price
$7.94
★ $117.50
AVG Volume (30 Days)
12.3K
★ 79.6K
Earning Date
11-27-2026
11-09-2026
Dividend Yield
N/A
★ 0.50%
EPS Growth
N/A
★ 436.11
EPS
N/A
★ 0.49
Revenue
N/A
N/A
Revenue This Year
N/A
$2.14
Revenue Next Year
N/A
$6.45
P/E Ratio
★ N/A
$261.20
Revenue Growth
N/A
N/A
52 Week Low
$4.07
$69.51
52 Week High
$6.16
$144.35

Technical Indicators

Market Signals
Indicator
AUXX
MLAB
Relative Strength Index (RSI) 22.76 50.81
Support Level N/A $120.65
Resistance Level $4.88 $132.70
Average True Range (ATR) 0.25 4.66
MACD -0.02 -0.47
Stochastic Oscillator 14.14 26.63

Price Performance

Historical Comparison
AUXX
MLAB

About AUXX Gold X2 Mining Inc. Common Shares

Gold X2 Mining Inc is a gold-focused Canadian mineral exploration company. Its primary business is the acquisition and exploration of precious metal mineral properties in Canada. Gold X2 currently holds title to the Moss Gold Project, Hillcrest Project, and an option to earn into the Vanguard Project, Coldstream Project, and Huronian Project located in Ontario, Canada.

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Share on Social Networks: